Edition of One · Clinician

What changed around your practice, read for you.

New evidence on your methods and client groups, guideline updates, and the reimbursement, regulation and training that reach your practice, each with its source and the strength of the evidence.

  • Weekly
  • €10 / month incl. VAT
  • No pharma advertising
  • Nothing about your clients
The Costa Edition Practice Notes · 11 October 2026

Guidelines and guidance

NICE draft guideline on OCD and body dysmorphic disorder: comments by 21 October

NICE · draft published 17 Sep 2026 · consultation open until 21 Oct 2026 · matched care instead of a fixed stepped pathway

Why for you: The draft asks clinicians to consider assessing for OCD in people with depression or anxiety, most of your caseload. A reason to add a few OCD screening questions to your intake interview.

New evidence

Long-term psychodynamic psychotherapy for depression: a meta-analysis of 16 randomised trials

Depression and Anxiety · 23 Sep 2026 · 16 RCTs, n = 1,992 · SMD 0.34 against all comparators, 0.27 against active treatments

Why for you: High-certainty evidence for the long therapies you offer, with effects holding at follow-up: cite it when an insurer or referrer questions a course of 30 sessions or more. The authors found little data on functioning, so measure it in your own cases.

Fictional reader, real items

In each issue

Six sections, about nine items

  • New evidenceNew research close to your methods, client groups and setting: systematic reviews and meta-analyses first, then large or well-designed studies. One finding at a time, with study type and sample size.
  • Guidelines and guidanceNew and updated treatment guidelines and official guidance that touch your work, from national bodies, NICE, Cochrane, WHO and professional associations. What changed and when, including drafts out for consultation.
  • Your systemReimbursement and insurers, health services, bills and laws, licensing and the regulator where you practise. Always the stage and the date it takes effect.
  • In the professionWhat professional and scientific associations and journals published: statements, ethics, working conditions, appointments.
  • Training and eventsContinuing education, specialist and psychotherapy training with open applications, and conferences that fit your methods. Organiser, dates, price and deadline, always with at least a week to act.
  • Worth readingOne longer piece: an essay, interview, review article or book close to your work.

Every source is primary and independent: the journal or PubMed record, the guideline body, the authority or the law. No drug or device advertising, no industry-funded training.

How it works

Name and email. The rest is our job.

  1. Leave your name and email. If you like, add your methods and client groups; they help us choose the right research.
  2. Your first issue arrives within a day, written for you alone. Then weekly.
  3. Reply to any issue (“more research”, “less on insurers”) or mark items with one click, and the next one follows.

Our promise

What an issue is not

Nothing about your clients or patients is ever kept or mentioned. No drug or device advertising, no industry-funded training.

Price

First week free, then one price

One price, VAT included.

First week €0

Your first week is free, and your first issue arrives within a day. No card details, no commitment. We ask before charging anything.

Join

Start your free weekOpening soon

Your name and email are enough to start. Finding out what matters to you is our job; anything you add below only sharpens your first issue.

We use public information about your work and what you tell us. Never your health, religion or beliefs, home address or finances. Once your issues start, you can see and correct what we know on your own page. Privacy notice

Questions

Before you sign up

Is this clinical decision support?

No. Decision-support tools answer “what do I do with this patient”. We gather what changed around your work: new evidence on your methods, guideline updates, the rules and reimbursement where you practise, training. Every item says what the source says, not what you should do.

Why not just ask ChatGPT?

You can, if you know what to ask. We start from your work instead, and find the studies, guideline changes and training you had no reason to search for, each linked to its source. More on this.

How is this different from journal alerts?

Alerts match keywords and send everything. We read the sources and keep what concerns your methods, client groups and setting, and add what no alert covers: regulation, reimbursement, law and training deadlines.

Where do you cover?

Evidence and international guidance from anywhere, and the system you work in: the authorities, insurers and laws of the country where you practise.

Is there drug or device advertising?

Never. No ads, no sponsored items, no industry-funded training. On drug safety we report only authorities and independent sources.

Who pays, me or my employer?

Either. Many employers pay for continuing professional development, and keeping up with your field is part of it. We ask before charging anything.

What do you use about me?

Public information about your work, with your consent, and what you tell us. You can see and correct it on your own page. Details in the privacy notice.

How do I stop it?

Reply “stop” to any issue.